As of 2024-12-14, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is -0.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is 6.83 mil USD. STRO's TTM EBITDA according to its financial statements is -151.54 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.6x | 14.9x |
| Forward P/E multiples | 15.5x - 23.8x | 18.1x |
| Fair Price | (26.37) - (28.46) | (28.21) |
| Upside | -1298.5% - -1393.8% | -1382.1% |
| Date | EV/EBITDA |
| 2024-12-11 | -0.18 |
| 2024-12-10 | -0.13 |
| 2024-12-09 | -0.38 |
| 2024-12-06 | -0.39 |
| 2024-12-05 | -0.36 |
| 2024-12-04 | -0.39 |
| 2024-12-03 | -0.35 |
| 2024-12-02 | -0.34 |
| 2024-11-29 | -0.29 |
| 2024-11-27 | -0.31 |
| 2024-11-26 | -0.26 |
| 2024-11-25 | -0.27 |
| 2024-11-22 | -0.21 |
| 2024-11-21 | -0.22 |
| 2024-11-20 | -0.30 |
| 2024-11-19 | -0.32 |
| 2024-11-18 | -0.34 |
| 2024-11-15 | -0.42 |
| 2024-11-14 | -0.73 |
| 2024-11-13 | -1.00 |
| 2024-11-12 | -1.07 |
| 2024-11-11 | -1.24 |
| 2024-11-08 | -1.23 |
| 2024-11-07 | -1.11 |
| 2024-11-06 | -1.10 |
| 2024-11-05 | -0.94 |
| 2024-11-04 | -0.86 |
| 2024-11-01 | -0.78 |
| 2024-10-31 | -0.62 |
| 2024-10-30 | -0.79 |
| 2024-10-29 | -0.78 |
| 2024-10-28 | -0.80 |
| 2024-10-25 | -0.73 |
| 2024-10-24 | -0.73 |
| 2024-10-23 | -0.75 |
| 2024-10-22 | -0.77 |
| 2024-10-21 | -0.83 |
| 2024-10-18 | -0.88 |
| 2024-10-17 | -0.87 |
| 2024-10-16 | -0.90 |
| 2024-10-15 | -0.93 |
| 2024-10-14 | -0.93 |
| 2024-10-11 | -0.91 |
| 2024-10-10 | -0.65 |
| 2024-10-09 | -0.73 |
| 2024-10-08 | -0.76 |
| 2024-10-07 | -0.78 |
| 2024-10-04 | -0.81 |
| 2024-10-03 | -0.77 |
| 2024-10-02 | -0.76 |